Cite

HARVARD Citation

    Mountzios, G. et al. (2019). Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab. ESMO open. 4 (2), p. . [Online]. 
  
Back to record